Salesforce (CRM) Tops Q3 EPS by 35c, Offers Q4 Guidance
Tweet
Share
E-mail
Get Alerts CRM Hot Sheet
Price: $193.32 --0%
Revenue Growth %: +11.1%
Financial Fact:
Shares used in computing basic net income per share: 690.47M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Revenue Growth %: +11.1%
Financial Fact:
Shares used in computing basic net income per share: 690.47M
Today's EPS Names:
VAXX, NMRD, EGRX, More
Join SI Premium – FREE
Salesforce (NYSE: CRM) reported Q3 EPS of $1.27, $0.35 better than the analyst estimate of $0.92. Revenue for the quarter came in at $6.86 billion versus the consensus estimate of $6.79 billion.
GUIDANCE:
Salesforce sees Q4 2022 EPS of $0.72-$0.73, versus the consensus of $0.81. Salesforce sees Q4 2022 revenue of $7.224-7.234 billion, versus the consensus of $7.22 billion.
For earnings history and earnings-related data on Salesforce (CRM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Assumes salesforce.com (CRM) at Overweight, 'Overblown Concerns'
- Pyxis Oncology, Inc. (PYXS) Misses Q2 EPS by 4c
- Beyond Air, Inc. (XAIR) Tops Q1 reported Q1 Revenue ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
